- Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation — Recruiting • Cardiology / Cardiovascular • NCT07436299.
- What is being tested: Novel echocardiographic technologies and methods to improve the accuracy of measuring left ventricular filling pressure in patients with concurrent heart failure and atrial fibrillation, addressing current diagnostic limitations in this high-risk population.
- Patient eligibility overview: The trial targets patients with the dual diagnosis of heart failure and atrial fibrillation, representing approximately 50% of the heart failure population—a substantial group currently facing diagnostic challenges with conventional echocardiographic assessment.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
Heart failure and atrial fibrillation are two of the most common heart diseases globally. Nearly half of all patients with heart failure also have atrial fibrillation. When heart failure and atrial fibrillation occur together, the risk of hospitalization and premature death increases significantly. However, there is a lack of reliable tools to assess how severely the heart is affected in these patients. This makes it difficult both to establish the correct diagnosis, tailor treatment, and predict who is at greatest risk of hospital admission or death from the disease. One…
- : * Atrial fibrillation (paroxysmal, persistent, or permanent) * Scheduled for RHC or LHC for clinical reasons * Able to undergo echocardiography and invasive pressure measurement within 8 hours * No cardiovascular medication changes between echo and catheterization * Written informed consent provided
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.